Clinical trial
The Role of Confocal Microscopy in Estimating Dupilumab Treatment Response for Moderate/Severe Atopic Dermatitis
NCT07098000 is registered in ClinicalTrials.gov with Hospital Italiano de Buenos Aires as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Confocal Microscopy in Estimating Dupilumab Treatment Response for Moderate/Severe Atopic Dermatitis
- Lead sponsor
- Hospital Italiano de Buenos Aires
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 24, 2024
- Completion date
- April 9, 2026
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis